Research graph
References from Upadacitinib for chronic spontaneous urticaria in patients with concomitant atopic dermatitis: A retrospective study of 31 cases. Local targets link to admitted publications; unresolved targets remain external evidence.
Chronic spontaneous urticaria: a review
10.1001/jama.2024.15568 · 2024 · External reference
JAK inhibitors in the treatment of atopic dermatitis
10.1016/j.jaci.2021.08.009 · 2021 · External reference
Advances in atopic dermatitis and urticarial in 2016
10.1016/j.jaci.2017.06.005 · 2017 · External reference
IgG and IgE autoantibodies to IgE receptors in chronic spontaneous urticaria and their role in the response to omalizumab
10.3390/jcm12010378 · 2023 · External reference
Experimental and clinical evidence suggests that treatment with Betacellulin can alleviate Th2-Type cytokine-mediated impairment of skin barrier function
10.3390/ijms231911520 · 2022 · External reference
D-Dimer plasma levels parallel the clinical response to omalizumab in patients with severe chronic spontaneous urticaria
10.1159/000453453 · 2017 · External reference
Eosinophilic cationic protein and D-Dimer are potential biomarkers to predict response to antihistamines but not to omalizumab in chronic spontaneous urticaria
10.1080/19932820.2024.2420483 · 2024 · External reference
Plasma fibrin clot properties in atopic dermatitis: links between thrombosis and atopy
10.1007/s11239-010-0478-0 · 2010 · External reference
Diagnostic testing for chronic spontaneous urticaria with or without angioedema: the do's, don't and maybe's
10.1016/j.waojou.2025.101068 · 2025 · External reference
